Phase II study of induction chemotherapy with gemcitabine and S-1 followed by chemoradiotherapy with S-1 in patients with locally advanced pancreatic cancer
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2017
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 01 Jul 2017 Primary endpoint has been met. (1-year survival rate), as reported in an article published in the Cancer Chemotherapy and Pharmacology.
- 01 Jul 2017 Results published in the Cancer Chemotherapy and Pharmacology
- 12 Apr 2016 Status changed from recruiting to completed.